Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic, Idiopathic

Explore clinical trials studying Purpura, Thrombocytopenic, Idiopathic. Study availability and eligibility vary by location and protocol.

321 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic, Idiopathic trial results

Recruiting

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

NCT07059000

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California Los Angeles, California, United States
  • NY Cancer and Blood Specialists Shirley, New York, United States
  • East Carolina University Greenville, North Carolina, United States
  • Vseobecna Fakultni Nemocnice v Praze Prague, Czechia
View all 28 locations
View Trial Details
Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

NCT07104565

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Palo Verde Cancer Specialists Palo Verde Hematology Oncology, Ltd Glendale Glendale, Arizona, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Lone Tree, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 40 locations
View Trial Details
Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

NCT06371417

Conditions
Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations
  • University of California-Irvine Orange, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Northwell Health, LLC PRIME Lake Success, New York, United States
  • Hospital for Special Surgery New York, United States
View all 77 locations
View Trial Details
Recruiting

Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease

NCT07549698

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +19 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Universitaetsklinikum Koeln Cologne, Germany
  • Medizinische Hochschule Hannover Hannover, Germany
View Trial Details
Recruiting

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

NCT07039422

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Roeselare, West-Vlaanderen, Belgium
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Dalian, Liaoning, China
View all 25 locations
View Trial Details
Recruiting

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

NCT07710248

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Pingdingshan First People's Hospital Pingdingshan, Henan, China
  • Jining No.1 People's Hospital Jining, Shandong, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

OM336 in Autoimmune Cytopenias

NCT07083960

Conditions
AIHA - Cold Autoimmune Hemolytic Anemia, AIHA - Warm Autoimmune Hemolytic Anemia, Anemia, +21 more
Locations
  • The Canberra Hospital Canberra, Australian Capital Territory, Australia
  • Liverpool Hospital Sydney, New South Wales, Australia
  • Icon Cancer Center South Brisbane Brisbane, Queensland, Australia
View Trial Details
Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View Trial Details
Recruiting

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

NCT06948318

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Georgetown University Medical Center - Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 109 locations
View Trial Details

Related conditions